Burkitt Lymphoma

  • George Miller


Burkitt lymphoma (BL) is a malignant lymphoma of children occurring with highest frequency in certain parts of Africa and New Guinea where malaria is hyperendemic. It is found in low frequency throughout the world and in nonmalarious areas.


Burkitt Lymphoma Infectious Mononucleosis Early Antigen Viral Capsid Antigen Burkitt Lymphoma Case 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collected reports of cases of Burkitt’s lymphoma from countries outside the endemic areas, Int. J. Cancer 2:559–609 (1967).Google Scholar
  2. 2.
    Adams, A., and Lindahl, T., Epstein—Barr virus genomes with properties of circular DNA molecules in carrier cells, Proc. Natl. Acad. Sci. U.S.A. 72:1477–1481 (1975).PubMedGoogle Scholar
  3. 3.
    Adams, A., Lindahl, T., and Klein, G., Linear association between cellular DNA and EBV DNA in a human lymphoblastoid cell line, Proc. Natl. Acad. Sci. U.S.A. 70:2888–2892 (1973).PubMedGoogle Scholar
  4. 4.
    Armenian, H. K., and Lillienfeld, A. M., The dis-tribution of incubation periods of neoplastic diseases, Am. J. Epidemiol. 99:92–100 (1974).PubMedGoogle Scholar
  5. 5.
    Banatvala, J. E., Best, J. M., and Waller, D. K., Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, and nasopharyngeal carcinoma, Lancet 1:1205–1208 (1972).PubMedGoogle Scholar
  6. 6.
    Bar, R. S., Delor, C. J., Clausen, K. P., Hurtubise, P., Henle, W., and Hewetson, J. F., Fatal infectious mononucleosis in a family, N. Engl. J. Med. 290:363–367 (1974).PubMedGoogle Scholar
  7. 7.
    Beard, C. W., O’conor, G. T., Thomas, L. B., and Torloni, H., Histopathological definition of Burkitt’s tumor, Bull. WHO 40:601–607 (1969).Google Scholar
  8. 8.
    Berry, C. G., Lymphoma syndrome in northern Nigeria, Br. Med. J. 2:668–670 (1964).PubMedGoogle Scholar
  9. 9.
    Biggar, R. J., Henle, W., Fleisher, G., Pröcker, J., Lennetre, E. T., and Henle, G., Primary Epstein-Barr virus infections in African infants. I. Decline of maternal antibodies and time of infection, Int. J. Cancer, 22:239–243 (1978).PubMedGoogle Scholar
  10. 10.
    Biggar, R. J., Henle, G., Bocher, J., Lennette, E. T:, Fleisher, G., and Henle, W., Primary Epstein-Barr virus infections in African infants. II. Chemical and serological observations during seroconversion, Int. J. Cancer 22:244–250 (1978).PubMedGoogle Scholar
  11. 11.
    Bornkamm, G. W., Stein, H., Lennart, K., Rüggeberg, F., Bartels, H., and Zur Hausen, H., Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and in immunoblastic lymphadenopathy with excessive plasmacytosis, Int. J. Cancer 17:177–181 (1976).PubMedGoogle Scholar
  12. 12.
    Britton, S., Andersson-Anvret, M., Gergely, P., Henle, W., Jondal, M., Klein, G., Sandstedt, B., and Svedmyr, E., Epstein-Barr virus immunity and tissue distribution in a fatal case of infectious mononucleosis, N. Engl. J. Med. 298:89–92 (1978).PubMedGoogle Scholar
  13. 13.
    Burkitt, D. P., A sarcoma involving the jaws in African children, Br. J. Surg. 46:218–223 (1958).PubMedGoogle Scholar
  14. 14.
    Burkitt, D. P., A children’s cancer dependent on climatic factors, Nature (London) 194:232–234 (1962).Google Scholar
  15. 15.
    Burkitt, D., Determining the climatic limitations of a children’s cancer common in Africa, Br. Med. J. 2:1019–1023 (1962).PubMedGoogle Scholar
  16. 16.
    Burkitt, D., Burkitt’s lymphoma outside the known endemic areas of Africa and New Guinea, Int. J. Cancer 2:562–565 (1967).PubMedGoogle Scholar
  17. 17.
    Burkitt, D., Etiology of Burkitt’s lymphoma-An alternative hypothesis to a vectored virus, J. Natl. Cancer Inst. 42:19–28 (1969).PubMedGoogle Scholar
  18. 18.
    Burkitt, D., and Wright, D. H., Geographical and tribal distribution of the African lymphoma in Uganda, Br. Med. J. 5487:569–573 (1966).Google Scholar
  19. 19.
    Bummr, D. P., and Wright, D. H. (eds.), Burkitt’s Lymphoma, Livingstone, Edinburgh, 1970.Google Scholar
  20. 20.
    Byrne, E. B., Evans, A. S., Fomrs, D. W., and Israel, H. L., A seroepidemiological study of Epstein-Barr virus and other antigens in sarcoidosis, Am. J. Epidemioi. 97:355–363 (1973).Google Scholar
  21. 21.
    Carbone, P., Bernard, C. W., Bennett, J. M., Ziegler, J. L., Cohen, M. H., and Gerber, P., National Institutes of Health clinical staff conference: Burkitt’s tumor, Ann. Intern. Med. 70:817–832 (1969).PubMedGoogle Scholar
  22. 22.
    Carvalho, R. P. S., Evans, A. S., Frost, P., Dalldorf, G., Camargo, M. F., and Jamra, M., EBV in-fections in Brazil. I. Occurrence in normal persons, in lymphomas and in leukemias, Int. J. Cancer 11:191–201 (1973).PubMedGoogle Scholar
  23. 23.
    Chang, R. S., Lewis, J. P., and Abildgaard, C. F., Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population, N. Engl. J. Med. 289:1325–1329 (1973).PubMedGoogle Scholar
  24. 24.
    Churchill, A. E., Payne, L. N., and Chubb, R. C., Immunization against Marek’s disease using a live attenuated virus, Nature (London) 221:744–747 (1969).Google Scholar
  25. 25.
    Cook, A. R., Uganda Memories, Uganda Society, 1945.Google Scholar
  26. 26.
    Coope, D., Heston, L., Brandsma, J., and Miller, G., Cross neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera, J. Immunol. 123:232–238 (1979).PubMedGoogle Scholar
  27. 27.
    Dalldorf, G., Lymphomas of African children. J. Am. Med. Assoc. 181:1026–1028 (1962).Google Scholar
  28. 28.
    Dalldorf, G., Linsell, C. A., Barnhart, F. C., and Martyn, R., An epidemiologic approach to the lymphomas of African children and Burkitt’s sarcoma of the jaws, Perspect. Biol. Med. 7:435–449 (1964).PubMedGoogle Scholar
  29. 29.
    Dambaugh, T., Nkrumah, F. K., Biggar, R. J., and Kieff, E., Epstein-Barr virus RNA in Burkitt tumor tissue, Cell 16:313–322 (1979).PubMedGoogle Scholar
  30. 30.
    Davies, J. N. P., Elmes, S., Hurr, M. S. R., Mtimavalye, L. A. R., Owor, R., and Shaper, L., Cancer in an African community, 1897–1956: An analysis of the records of Mengo Hospital, Kampala, Uganda: Part 2, Br. Med. J. 1:336–341 (1964).PubMedGoogle Scholar
  31. 31.
    Dean, A. G., Williams, E. H., Attobua, G., Omeda, J., Cadi, A., Amuti, A., and Atima, S. B., Clinical events suggesting herpes-simplex infection before onset of Burkitt’s lymphoma, Lancet 2:1225–1228 (1973).PubMedGoogle Scholar
  32. 32.
    Delius, H., and Bornkamm, G. W., Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs, J. Virol. 27:81–89 (1978).PubMedGoogle Scholar
  33. 33.
    Deschryver, A., Klein, G., Henle, G., Henle, W., Cameron, H. M.,Santesson, L., and Clifford, P., EB-virus associated serology in malignant disease: Antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens (EA) in patients with various neoplastic conditions, Int. J. Cancer 9:353–364 (1972).Google Scholar
  34. 34.
    De-Thé, G., Geser, A., Day, N. E., Tubei, P. M., Williams, E. H., Beir, D. P., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P., and Henle, W., Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt’s lymphoma from Ugandan prospective study, Nature (London) 274:756–761 (1978).Google Scholar
  35. 35.
    Einhorn, N., Henle, G., Henle, W., Klein, G., and Clifford, P., Effect of local radiotherapy on the antibody levels against EBV-induced early and capsid antigens (EA and VCA) in patients with certain malignant tumours, Int. J. Cancer 9:182 (1972).PubMedGoogle Scholar
  36. 36.
    Epstein, M. A., Achong, B. G., Barr, Y. M., Zajac, B., Henle, G., and Henle, W., Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji), J. Natl. Cancer Inst. 34:547–559 (1966).Google Scholar
  37. 37.
    Epstein, M. A., and Barr, Y. M., Cultivation in vitro of human lymphoblasts from Burkitt’s malignant lymphoma, Lancet 1:252–253 (1964).PubMedGoogle Scholar
  38. 38.
    Epstein, M. A., Henle, G., Achong, B. G., and Barr, Y. M., Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt’s lymphoma, J. Exp. Med. 121:761–770 (1965).PubMedGoogle Scholar
  39. 39.
    Epstein, M. A., Achong, B. G., and Barr, Y. M., Virus particles in cultured lymphoblasts from Burkitt’s lymphoma, Lancet 1:702–703 (1964).PubMedGoogle Scholar
  40. 40.
    Epstein, M. A., Hunt, R. D., and Rabin, H., Pilot experiments with EB virus in owl monkeys (Aotus trivirgatus). I. Reticuloproliferative disease in an inoculated animal, Int. J. Cancer 12:309–318 (1973).PubMedGoogle Scholar
  41. 41.
    Falk, L., Wolfe, L., Deinhardt, F., Paciga, J., Dombos, L., Klein, G., Henle, W., and Henle, G., Epstein-Barr virus: Transformation of non-human primate lymphocytes in vitro,Int. J. Cancer 13:353–376 (1974).Google Scholar
  42. 42.
    Fass, L., Herberman, R. B., and Ziegler, J., Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells, N. Engl. J. Med. 282:776–780 (1970).PubMedGoogle Scholar
  43. 43.
    Fialkow, P. J., Klein, E., Klein, G., Clifford, P., and Singh, S., Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma, J. Exp. Med. 138:89–101 (1973).PubMedGoogle Scholar
  44. 44.
    Fleckenstein, B., Daniel, M. D., and Hunt, R. D., Tumor induction with DNA of oncogenic primate herpesviruses, Nature (London) 274:57–59 (1978).Google Scholar
  45. 45.
    Fleisher, G., Henle, W., Henle, G., Lennette, E. T., and Biggar, R. J.,Primary infection with Epstein-Barr virus in infants in the the United States: Clinical and serologic observations, J. Infect. Dis. 139:553–558 (1979).PubMedGoogle Scholar
  46. 46.
    Gerber, P., Activation of Epstein-Barr virus by 5-bromodeoxyuridine in virus free human cells, Proc. Natl. Acad. Sci. U.S.A. 69:83–85 (1972).PubMedGoogle Scholar
  47. 47.
    Gerber, P., and Hoyer, B. H., Induction of cellular DNA synthesis in human leucocytes by Epstein-Barr virus, Nature (London) 231:46–47 (1971).Google Scholar
  48. 48.
    Gerber, P., Nkrumah, F. K., Pritchett, R., and Kieff, E., Comparative studies of Epstein-Barr virus strains from Ghana and the United States, Int. J. Cancer 17:71–81 (1976).PubMedGoogle Scholar
  49. 49.
    Given, D., and Kieff, E., DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95–8 and W91 strains of Epstein-Barr virus, J. Virol. 28:524–542 (1978).PubMedGoogle Scholar
  50. 50.
    Glaser, R., and Rapp, F., Rescue of Epstein-Barr virus from somatic cell hybrids of Burkitt lymphoblastoid cells, J. Virol. 10:288–296 (1972).PubMedGoogle Scholar
  51. 51.
    Griffin, E. R., Wright, D. H., Bell, T. M., and Ross, M. G. R., Demonstration of virus particles in biopsy material from cases of Burkitt’s tumour, Eur. J. Cancer 2:353–358 (1966).PubMedGoogle Scholar
  52. 52.
    Gunven, P., Klein, G., Clifford, P., and Singh, S., Epstein-Barr virus-associated membrane-reactive antibodies during long term survival after Burkitt’s lymphoma, Proc. Natl. Acad. Sci. U.S.A. 71:1422–1426 (1974).PubMedGoogle Scholar
  53. 53.
    Hampar, B., Derge, J. G., Martos, L. M., Tagamets, M. A., Change, S. Y., and Chakrabarty, M., Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine, Nature (London) New Biol. 244:214–217 (1973).Google Scholar
  54. 54.
    Hampar, B., Derge, J. G., Martos, L. M., and Walker, J. L., Synthesis of Epstein-Barr virus after activation of the viral genome in a virus negative human lymphoblastoid cell (Raji) made resistant to five bromodeoxyuridine, Proc. Natl. Acad. Sci. U.S.A. 69:78–82 (1972).PubMedGoogle Scholar
  55. 55.
    Henderson, E., Robinson, J., Frank, A., and Miller, G., Epstein-Barr virus: Transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light, Virology 82:196–205 (1977).PubMedGoogle Scholar
  56. 56.
    Henle, G., and Henle, W., Immunof1uorescence in cells derived from Burkitt’s lymphoma, J. Bacteriol. 91:1248–1256 (1966).PubMedGoogle Scholar
  57. 57.
    Henle, G., Henle, W., Clifford, P., Diehl, V., Kafuko, G. W., Kirya, B. G., Klein, G., Morrow, R. H., Munube, G. M., R., Pike, M. C., Tukei, P. M., and Ziegler, J. L., Antibodies to Epstein-Barr virus in Burkitt’s lymphoma and control groups, J. Natl. Cancer Inst. 43:1147–1157 (1969).PubMedGoogle Scholar
  58. 58.
    Henle, W., Diehl, V., Kohn, G., Zur Hausen, H., and Henle, G., Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells, Science 157:1064–1065 (1967).PubMedGoogle Scholar
  59. 59.
    Henle, W., Henle, G., Gunven, P., Klein, G., Clifford, P., and Singh, S., Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt’s lymphoma: Comparison of dying patients with long term survivors, J. Natl. Cancer Inst. 50:1163–1173 (1973).PubMedGoogle Scholar
  60. 60.
    Henle, W., Henle, G., Zajac, B. A., Pearson, G., Waubke, R., and Scriba, M., Differential reactivity of human serums with early antigens induced by Epstein-Barr virus, Science 169:188–190 (1970).PubMedGoogle Scholar
  61. 61.
    Hilgers, J., Dean, A. G., and De-Thé, G. B., Elevated immunofluorescence titers to several herpes viruses in Burkitt’s lymphoma patients: Are high titers unique? J. Natl. Cancer Inst. 54:49–51 (1975).PubMedGoogle Scholar
  62. 62.
    Hinuma, Y., Konn, M., Yamaguchi, J., Wudarski, D. J., Blakeslee, J. R., and Grace, J. T., JR., Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line, J. Virol. 1:1045–1051 (1967).PubMedGoogle Scholar
  63. 63.
    Hirshaut, Y., Cohen, M. H., and Stevens, D. A., Epstein-Barr virus antibodies in American and African Burkitt’s lymphoma, Lancet 2:114–116 (1973).PubMedGoogle Scholar
  64. 64.
    Jondal, M., and Klein, G., Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes, J. Exp. Med. 138:1365–1378 (1973).PubMedGoogle Scholar
  65. 65.
    Jondal, M., Svedmyr, E., and Klein, E., Killer T cells in a Burkitt’s lymphoma biopsy, Nature (London) 255:405–407 (1975).Google Scholar
  66. 66.
    Judson, S. C., Henle, W., and Henle, G., A cluster of Epstein-Barr virus-associated American Burkitt’s lymphoma, N. Engl. J. Med. 297:464–468 (1977).PubMedGoogle Scholar
  67. 67.
    Kafuko, G. W., and Burkitt, D. P., Burkitt’s lymphoma and malaria, Int. J. Cancer 6:1–9 (1970).PubMedGoogle Scholar
  68. 68.
    Kafuko, G. W., Henderson, B. E., Kirya, B. G., Mu-Nube, G. M. R., Tukei, P. M., Day, N. E., Henle, G., Henle, W., Morrow, R. H., Pike, M. C., Smith, P. G., and Williams, E. H., Epstein-Barr virus antibody levels in children from the West Nile District of Uganda, Lancet 1:706 (1972).PubMedGoogle Scholar
  69. 69.
    Kaschka-Dierich, C., Adams, A., Lindahl, T., Born-Kamm, G., Bjursell, G., Klein, G., Giovanella, B., and Singh, S., Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo, Nature (London) 260:302–306 (1976).Google Scholar
  70. 70.
    Kinter, C. R., and Sugden, B., The structure of the termini of the DNA of Epstein-Barr virus, Cell 17:661–672 (1979).Google Scholar
  71. 71.
    Klein, G., Clifford, P., Klein, E., and Stjernsward, J., Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction, Proc. Natl. Acad. Sci. U.S.A. 55:1628–1635 (1966).PubMedGoogle Scholar
  72. 72.
    Klein, G., Lindahl, T., Jondal, M., Leibold, W., Ménézes, J., Nilsson, K., and Sundström, C., Continuous lymphoid cell lines with B-cell characteristics that lack the Epstein-Barr virus genome, derived from three human lymphomas, Proc. Natl. Acad. Sci. U.S.A. 71:3283–3286 (1974).PubMedGoogle Scholar
  73. 73.
    Kufe, D., Hehlmann, R., and Spiegelman, S., RNA related to that of a murine leukemia virus in Burkitt’s tumors and nasopharyngeal carcinoma, Proc. Natl. Acad. Sci. U.S.A. 70:5–9 (1973).PubMedGoogle Scholar
  74. 74.
    Levine, P. H., Ablashi, D. V., and Berard, C. W., Elevated antibody titers to Epstein-Barr virus in Hodgkin’s disease, Cancer 27:416–421 (1971).PubMedGoogle Scholar
  75. 75.
    Levine, P. H., O’conor, G. T., and Berard, C. W., Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt’s lymphoma, Cancer 30:610–615 (1972).PubMedGoogle Scholar
  76. 76.
    Levy, J. A., and Henle, G., Indirect immunofluorescence tests with sera from African children and cultured Burkitt lymphoma cells, J. Bacteriol, 92:275–276 (1966).PubMedGoogle Scholar
  77. 77.
    Lindahl, T., Klein, G., Reedman, B. M., Johanson, B., and Singh, S., Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies, Int. J. Cancer 13:764–772 (1974).PubMedGoogle Scholar
  78. 78.
    Luka, J., Lindahl, T., and Klein, G., Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines, J. Virol. 27:604–611 (1978).PubMedGoogle Scholar
  79. 79.
    Miller, G., Oncogenicity of Epstein-Barr virus, J. Infect. Dis. 130:187–205 (1974).PubMedGoogle Scholar
  80. 80.
    Miller, G., and Coope, D., Epstein-Barr viral nuclear antigen (EBNA) in tumor cell imprints of experimental lymphoma of marmosets, Trans. Assoc. Am. Physicians 87:205–218 (1974).PubMedGoogle Scholar
  81. 81.
    Miller, G., and Lipman, M., Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus, J. Exp. Med. 138:1398–1412 (1973).PubMedGoogle Scholar
  82. 82.
    Miller, G., Lisco, H., Kohn, H. I., and Stitt, D., Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody, Proc. Soc. Exp. Biol. Med. 137:1459–1465 (1971).PubMedGoogle Scholar
  83. 83.
    Miller, G., Niederman, J. C., and Andrews, L., Prolonged oropharyngeal excretion of EB virus following infectious mononucleosis, N. Engl. J. Med. 288:229–232 (1973).PubMedGoogle Scholar
  84. 84.
    Miller, G., Robinson, J. Heston, L., and Lipman, M., Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference, Proc. Natl. Acad. Sci. U.S.A. 71:4006–4010 (1974).PubMedGoogle Scholar
  85. 85.
    Miller, G., Shope, T., Coope, D., Waters, L., Pagano, J., Bornkamm, G. W., and Henle, W., Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: Tumor incidence, histologic spectrum, antibody responses, demonstration of viral DNA, and characterization of viruses, J. Exp. Med. 145:948–967 (1977).PubMedGoogle Scholar
  86. 86.
    Miller, G., Shope, T., Lisco, H., Stitt, D., and Lip-Man, M., Epstein-Barr virus: Transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes, Proc. Natl. Acad. Sci. U.S.A. 69:383–387 (1972).PubMedGoogle Scholar
  87. 87.
    Miller, M. H., Stitt, D., and Miller, G., Epstein-Barr viral antigen in single cell clones of two human leukocytic lines, J. Virol. 6:699–701 (1970).PubMedGoogle Scholar
  88. 88.
    Morrow, R. H., Pike, M. C., and Smith, P. G. Epidemiology of Burkitt’s lymphoma in the Mengo Districts, Uganda, 1957–1968, Presented at the annual meeting of the American Epidemiological Society, April 5–6, 1974.Google Scholar
  89. 89.
    Morrow, R. H., Pike, M. C., Smith, P. G., Ziegler, J. L., and Kisuule, A., Burkitt’s lymphoma: A time-space cluster of cases in Bwamba County of Uganda, Br. Med. J. 2:491–492 (1971).PubMedGoogle Scholar
  90. 90.
    Nadkarni, J. S., Nadkarni, J. J., Klein, G., Henle, W., Henle, G., and Clifford, P., EB viral antigens in Burkitt tumor biopsies and early cultures, Int. J. Cancer 6:10–17 (1970).PubMedGoogle Scholar
  91. 91.
    Niederman, J., Miller, G., Pearson, H., and Pagano, J., Patterns of excretion of Epstein-Barr virus in saliva and other oropharyngeal sites during infectious mononucleosis, N. Engl. J. Med. 294:1355–1359 (1976).PubMedGoogle Scholar
  92. 92.
    Nonoyama, M., Huang, C. H., Pagano, J. S., Klein, G., and Singh, S., DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and naso-pharyngeal carcinoma, Proc. Natl. Acad. Sci. U.S.A. 70:3265–3268, (1973).PubMedGoogle Scholar
  93. 93.
    Nonoyama, M., and Pagano, J. S., Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus producing cells, Nature (London) New Biol. 238:169 (1972).Google Scholar
  94. 94.
    O’conor, G. T., Malignant lymphoma in African children. II. A pathological entity, Cancer 14:270–283 (1961).PubMedGoogle Scholar
  95. 95.
    O’conor, G. T., Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt’s tumor, Am. J. Med. 48:279–285 (1970).Google Scholar
  96. 96.
    Old, L. J., Boyse, E. A., Oettgen, H. F., Deharven, E., Geering, G., Williamson, B., and Clifford, P., Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells, Proc. Natl. Acad. Sci. U.S.A. 56:1669–1704 (1966).Google Scholar
  97. 97.
    Pearson, G. R., and Qualtiere, L. T., Papain solu bilization of the Epstein-Barr virus-induced membrane antigen, J. Virol. 28:344–351 (1978).PubMedGoogle Scholar
  98. 98.
    Pike, M. C., Morrow, R. H., Kisuule, A., and Mafigiri, J., Burkitt’s lymphoma and sickle cell trait, Br. J. Prey. Soc. Med. 24:39–41 (1970).Google Scholar
  99. 99.
    Pike, M. C., Williams, E. H., and Wright, B., Burkitt’s tumour in the West Nile District of Uganda 1961–5, Br. Med. J. 2:395–399 (1967).PubMedGoogle Scholar
  100. 100.
    Pope, J. H., Horne, M. K., and Scott, W., Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus, Int. J. Cancer 4:255–260 (1969).PubMedGoogle Scholar
  101. 101.
    Powell, A. L. T., King, W., and, Kieff, E., Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection, J. Virol. 29:261–274 (1979).PubMedGoogle Scholar
  102. 102.
    Pulvertaft, R. J. V., Cytology of Burkitt’s tumor (African lymphoma), Lancet 1:238–240 (1964).PubMedGoogle Scholar
  103. 103.
    Purtilo, D. T., De Florio, D., Huti-, L. M., Bhawan, J., Yang, J. P. S., Otto, R., and Edwards, W., Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome, N. Engl. J. Med. 297:1077–1081 (1977).PubMedGoogle Scholar
  104. 104.
    Reedman, B. M., and Klein, G., Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines, Int. J. Cancer 11:499–520 (1973).PubMedGoogle Scholar
  105. 105.
    Reedman, B. M., Klein, G., Pope, J. H., Waiters, M. L., Hilgers, J., Singh, S., and Johansson, B.,Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies, Int. J. Cancer 13:755–763 (1974).PubMedGoogle Scholar
  106. 106.
    Robinson, J., and Miller, G., Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood, J. Virol. 15:1065–1072 (1975).PubMedGoogle Scholar
  107. 107.
    Rymo, L., and Forsblom, S., Cleavage of Epstein-Barr virus DNA by restriction endonucleases EcoRI, Hind III, and Bam I, Nucleic Acids Res. 5:1387–1402 (1978).PubMedGoogle Scholar
  108. 108.
    Schmitz, H., and Scherer, M., IgM antibodies to Epstein-Barr virus in infectious mononucleosis, Arch. Gesamte Virusforsch. 37:332–339 (1972).PubMedGoogle Scholar
  109. 109.
    Schulte-Holthausen, H., and ZUR Hausen, H., Partial purification of the Epstein-Barr virus and some properties of its DNA, Virology 40:776–779 (1970).PubMedGoogle Scholar
  110. 110.
    Shope, T., Dechairo, D., and Miller, G., Malignant lymphoma in cotton-top marmosets following inoculation of Epstein-Barr virus, Proc. Natl. Acad. Sci. U.S.A. 70:2487–2491 (1973).PubMedGoogle Scholar
  111. 111.
    Stjernsward, J., Clifford, P., and Svedmyr, E., General and tumor destructive cellular immunological reactivity, in: Burkitt’s Lymphoma (D. P. Burkitt and D. H. Wright, eds.), pp. 164–171, Livingstone, Edinburgh, 1970.Google Scholar
  112. 112.
    Strauch, B., Siegel, N., Andrews, L., and Miller, G., Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs, Lancet 1:234–237 (1974).PubMedGoogle Scholar
  113. 113.
    Sugden, B., Comparison of Epstein-Barr viral DNA’s in Burkitt lymphoma biopsy cells and in cells clonally transformed in vitro, Proc. Natl. Acad. Sci. U.S.A. 74:4651–4655 (1977).PubMedGoogle Scholar
  114. 114.
    Sugden, D., and Mark, W., Clonal transformation of adult human leukocytes by Epstein-Barr virus, J. Virol. 23:503–508 (1978).Google Scholar
  115. 115.
    Svedmyr, E., and Jondal, M., Cytotoxic effector cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis, Proc. Natl. Acad. Sci. U.S.A. 72:1622–1626 (1975).PubMedGoogle Scholar
  116. 116.
    Vanier, T. M., and Pike, M. C., Leukemia incidence in tropical Africa, Lancet 1:512–513 (1967).Google Scholar
  117. 117.
    Walters, M. K., and Pope, J. H., Studies of the EB virus-related antigens of human leukocyte cell lines, Int. J. Cancer 8:32–40 (1971).PubMedGoogle Scholar
  118. 118.
    Werner, J., Henle, G., Pinto, C. A., Haff, R. F., and Henle, W., Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar),Int. J. Cancer 10:557–567 (1972).PubMedGoogle Scholar
  119. 119.
    Williams, E. H., Day, N. E., and Geser, A. G., Seasonal variation in onset of Burkitt’s lymphoma in the West Nile District of Uganda, Lancet 2:19–22 (1974).PubMedGoogle Scholar
  120. 120.
    Witkey, I. S., Malignant lymphoma in Papua, New Guinea: Epidemiologic aspects, J. Natl. Cancer Inst. 50:1703–1711 (1973).Google Scholar
  121. 121.
    Wolf, H., Werner, J., and Zur Hausen, H., EBV DNA in nonlymphoid cells of nasopharyngeal carcinomas and in a malignant lymphoma obtained after inoculation of EBV into cottontop marmosets, Cold Spring Harbor Symp. Quant. Biol. 39:791–796Google Scholar
  122. 122.
    Wolf, H., Zur Hausen, H., and Becker, V., EB viral genomes in epithelial nasopharyngeal carcinoma cells, Nature (London) New Biol. 244:245–247 (1973).Google Scholar
  123. 123.
    Yamamoto, N., and Hinuma, Y., Clonal transfor mation of human leukocytes by Epstein-Barr virus in soft agar, Int. J. Cancer 17:191–196 (1976).PubMedGoogle Scholar
  124. 124.
    Zech, L., Haglund, A., Nilsson, K., and Klein, G., Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas, Int. J. Cancer 17:47–56 (1976).PubMedGoogle Scholar
  125. 125.
    Ziegler, J. L., Andersson, M., Klein, G., and Henle, W., Detection of Epstein-Barr virus DNA in American Burkitt’s lymphoma, Int. J. Cancer 17:701–706 (1976).PubMedGoogle Scholar
  126. 126.
    Ziegler, J. L., Morrow, R. H., Jr., Templeton, A. C., Templeton, C., Bluming, A. Z., Fass, L., and Kyalwazi, S. K., Clinical features and treatment of childhood malignant lymphoma in Uganda, Int. J. Cancer 5:415–425 (1970).PubMedGoogle Scholar
  127. 127.
    Zur Hausen, H., and Schulte-Holthausen, H., Presence of EB virus nucleic acid homology in a “virus-free” line of Burkitt tumor cells, Nature (London) 227:245–248 (1970).Google Scholar
  128. 128.
    Zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., and Santesson, L., EB-virus DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx, Nature (London) 228:1056–1057 (1970).Google Scholar

Suggested Reading

  1. Epstein, M. A., and Achong, B., (eds), The Epstein-Barr Virus,Springer-Verlag Berlin, Heidelberg, New York, 1979.Google Scholar
  2. Miller, G., Biology of EB virus, in: Viral Oncology (G. Klein, ed.), pp. 713–738, Raven Press, New York, 1980.Google Scholar
  3. De-Thé, G., The epidemiology of Burkitt lymphoma, Epidemiol. Rev. 1:32–54, (1979).Google Scholar
  4. Henle, W., Henle, G., and Lennette, E. T., The Epstein-Barr virus. Sci. Am. 241:48–59 (1979).Google Scholar

Copyright information

© Plenum Publishing Corporation 1984

Authors and Affiliations

  • George Miller
    • 1
  1. 1.Department of Pediatrics and Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations